CN102274372B - Traditional Chinese medicine for treating traumatic fracture rheumatism and various types of hemorrhage - Google Patents
Traditional Chinese medicine for treating traumatic fracture rheumatism and various types of hemorrhage Download PDFInfo
- Publication number
- CN102274372B CN102274372B CN201110232502A CN201110232502A CN102274372B CN 102274372 B CN102274372 B CN 102274372B CN 201110232502 A CN201110232502 A CN 201110232502A CN 201110232502 A CN201110232502 A CN 201110232502A CN 102274372 B CN102274372 B CN 102274372B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- rhizoma
- rheumatism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating traumatic fracture rheumatism and various types of hemorrhage, belonging to the technical field of traditional Chinese medicines. The traditional Chinese medicine consists of the following bulk pharmaceuticals in parts by weight: 6-8 parts of arisaema cum bile, 6-8 parts of ground beetle, 6-8 parts of safflower, 6-8 parts of angelica root, 6-8 parts of szechuan lovage rhizome, 6-8 parts of cimicifuga dahurica, 6-8 parts of dragon's blood, 3-5 parts of keel, 3-5 parts of grassleaf sweelflag rhizome, 3-5 parts of pseudo-ginseng root, 3-5 parts of Chinese angelica, 3-5 parts of incised notopterygium rhizome, 9-11 parts of prepared myrrh, 12-14 parts of prepared frankincense, 7-9 parts of himalayan teasel root and 2-3 parts of borneol. The bulk pharmaceuticals are ground into powder and mixed into powder. The traditional Chinese medicine has the characteristics of short treatment course, quick response, no drug resistance and no toxic or side effect.
Description
Technical field
The invention belongs to technical field of Chinese medicines, be specifically related to a kind of exogenous injury rheumatism and various hemorrhage Chinese medicine of treating.
Background technology
Wound, fracture, rheumatism and various hemorrhage be clinical common diseases, damaged by external force collision, weapons, and paathogenic factor such as tumbling down wound causes the injured wound that is of skin and flesh muscles and bones, at present the Therapeutic Method poor effect.Modern treatment of fractures is exactly three big principles, promptly reset, fix and rehabilitation, but long more poor patient suffering's time of back of the course of treatment is long.Rheumatism is usually invaded joint, muscle, skeleton and soft tissue, and pain, swelling, joint function disturbance, these symptoms of generating heat are more outstanding, the antipyretic-antalgic antiinflammatory, and relief of symptoms is the primary and foremost purpose of this group disease of treatment.Rheumatismal treatment also need be carried out etiological treatment except the symptomatic treatment relief of symptoms.Hemorrhagely be divided into by the position: one, internal hemorrhage: intravital internal organs and tissue damaged hinder and the internal hemorrhage that causes, and blood flows in the body cavity, and appearance cannot see.Two, external haemorrhage: injured cause hemorrhage of body surface, blood flows out from wound.Very serious like untimely treatment consequence.
Summary of the invention
The objective of the invention is to for overcoming the weak point of prior art, a kind of exogenous injury rheumatism and various hemorrhage Chinese medicine of treating is provided, this Chinese medicine has short treating period, instant effect, the characteristics of no Drug resistance and toxic and side effects.
A kind of exogenous injury rheumatism and various hemorrhage Chinese medicine of treating that the present invention proposes; It is characterized in that; Crude drug by following weight ratio is formulated: Arisaema Cum Bile 6-8 part, Eupolyphaga Seu Steleophaga 6-8 part, Flos Carthami 6-8 part, Radix Angelicae Dahuricae 6-8 part, Rhizoma Chuanxiong 6-8 part, Rhizoma Cimicifugae 6-8 part, Sanguis Draxonis 6-8 part, Os Draconis 3-5 part, Rhizoma Acori Graminei 3-5 part, Radix Notoginseng 3-5 part, Radix Angelicae Sinensis 3-5 part, Rhizoma Et Radix Notopterygii 3-5 part, Myrrha (processed) 9-11 part, Olibanum (processed) 12-14 part, Radix Dipsaci 7-9 part, Borneolum Syntheticum 2-3 part, said each raw material pulverize is mixed and made into powder.
Pharmacology of the present invention: this Chinese medicine is got the pain relieving of Arisaema Cum Bile dispersing swelling and dissipating binds; Eupolyphaga Seu Steleophaga removing blood stasis with potent drugs blood, reuniting the fractured tendons and bones; Flos Carthami promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing; The Radix Angelicae Dahuricae induce sweat diffusing wind, sensible, pain relieving, dampness leukorrhagia stopping, detumescence and apocenosis; Rhizoma Chuanxiong blood-activating and qi-promoting, wind-expelling pain-stopping; Rhizoma Cimicifugae is delivered rash, heat-clearing and toxic substances removing, elevate a turnable ladder yang-energy; Sanguis Draxonis is invigorated blood circulation and is cured the wound, hemostasia and promoting granulation; Os Draconis tranquillizing the mind by relieving convulsion, suppressing the hyperactive liver and subsiding YANG, convergence are astringent or styptic treatment for spontaneous sweating; Rhizoma Acori Graminei resuscitation inducing and mind tranquilizing, removing dampness to restore normal function of the stomach; Radix Notoginseng removing stasis to stop bleeding, the analgesic therapy of invigorating blood circulation; Chinese angelica blood supplementing, invigorate blood circulation, regulating menstruation, pain relieving, intestine moistening; The Rhizoma Et Radix Notopterygii cold expelling dispels the wind, removing dampness to relieve pain; Myrrha (processed) promoting blood circulation and stopping pain, detumescence and promoting granulation; The pain relieving of Olibanum (processed) blood-activating and qi-promoting, detumescence and promoting granulation; Radix Dipsaci invigorating the liver and kidney, bone and muscle strengthening, arresting bleeding and miscarriage prevention, the continuous folding of curing the wound; Borneolum Syntheticum have one's ideas straightened out refreshment, clearing away heat to alleviate pain.
Characteristics of the present invention: this medicine is compatible to have removing blood stasis with potent drugs blood, reuniting the fractured tendons and bones, eliminating stasis and resolving masses, reducing swelling and alleviating pain, invigorate blood circulation cure the wound, hemostasia and promoting granulation, enrich blood, regulating menstruation, victory are wetly induced sweat, cold expelling dispels the wind effect, the characteristics of treatment exogenous injury rheumatism and various hemorrhage short treating period, instant effect.
The specific embodiment
Embodiment 1: the treatment wound is preferred: 6 parts of Arisaema Cum Bile, 6 parts of Eupolyphaga Seu Steleophagas, 6 parts on Flos Carthami, 6 parts of the Radixs Angelicae Dahuricae, 7 parts of Rhizoma Chuanxiongs, 6 parts of Rhizoma Cimicifugaes, 7 parts of Sanguis Draxonis, 4 parts of Os Draconis, 4 parts of Rhizoma Acori Graminei, 5 parts of Radix Notoginseng, 4 parts of Radix Angelicae Sinensis, 5 parts of Rhizoma Et Radix Notopterygiis, 11 parts of Myrrha (processed)s, 14 parts of Olibanum (processed)s, 9 parts of Radix Dipsacis, 3 parts of Borneolum Syntheticums, process powder.
Adopt outer wound patient 88 examples of Drug therapy of the present invention, male's 58 examples wherein, women's 30 examples.
Therapeutic Method
Chinese medicine of the present invention 5-10 gram for oral administration at every turn, affected part suitable amount used externally.2-3 time on the one.
Efficacy assessment standard
Wound clinical cure:, do not have an example to infect through using the recovery from illness in 5-7 days of this medicine.
The result
Traumatic patient is cured 88 examples, produce effects 0 example, invalid 0 example, cure rate: 100%, and total effective rate 100%.
Embodiment 2: treatment fracture is preferred: 7 parts of Arisaema Cum Bile, 7 parts of Eupolyphaga Seu Steleophagas, 7 parts on Flos Carthami, 7 parts of the Radixs Angelicae Dahuricae, 6 parts of Rhizoma Chuanxiongs, 8 parts of Rhizoma Cimicifugaes, 6 parts of Sanguis Draxonis, 3 parts of Os Draconis, 4 parts of Rhizoma Acori Graminei, 4 parts of Radix Notoginseng, 5 parts of Radix Angelicae Sinensis, 4 parts of Rhizoma Et Radix Notopterygiis, 10 parts of Myrrha (processed)s, 13 parts of Olibanum (processed)s, 8 parts of Radix Dipsacis, 2 parts of Borneolum Syntheticums, process powder.
Adopt Drug therapy fracture patient 66 examples of the present invention, male's 54 examples wherein, women's 12 examples.
Therapeutic Method
Chinese medicine of the present invention 5-15 gram for oral administration at every turn, affected part suitable amount used externally.2-3 time on the one.
Efficacy assessment standard
Fracture clinical cure:, wherein cure 60 examples, effective 6 examples through using this medicine 5-9 days.
The result
Fracture patient is cured 60 examples, produce effects 6 examples, invalid 0 example, cure rate: 90%, and total effective rate 100%.
Embodiment 3: treatment rheumatism is preferred: 8 parts of Arisaema Cum Bile, 8 parts of Eupolyphaga Seu Steleophagas, 8 parts on Flos Carthami, 7 parts of the Radixs Angelicae Dahuricae, 8 parts of Rhizoma Chuanxiongs, 6 parts of Rhizoma Cimicifugaes, 6 parts of Sanguis Draxonis, 4 parts of Os Draconis, 5 parts of Rhizoma Acori Graminei, 3 parts of Radix Notoginseng, 4 parts of Radix Angelicae Sinensis, 3 parts of Rhizoma Et Radix Notopterygiis, 9 parts of Myrrha (processed)s, 12 parts of Olibanum (processed)s, 7 parts of Radix Dipsacis, 3 parts of Borneolum Syntheticums, process powder.
Adopt Drug therapy rheumatic sufferers 98 examples of the present invention, male's 77 examples wherein, women's 21 examples.
Therapeutic Method
Chinese medicine of the present invention 5-12 gram for oral administration at every turn, affected part suitable amount used externally.2-3 time on the one.
Efficacy assessment standard
Rheumatism clinical cure:, wherein cure 91 examples, effective 7 examples through using this medicine 15-22 days.
The result
Rheumatic sufferers is cured 91 examples, produce effects 7 examples, invalid 0 example, cure rate: 92%, and total effective rate 100%.
Embodiment 4: treat various hemorrhage preferred: 6 parts of Arisaema Cum Bile, 7 parts of Eupolyphaga Seu Steleophagas, 6 parts on Flos Carthami, 8 parts of the Radixs Angelicae Dahuricae, 6 parts of Rhizoma Chuanxiongs, 7 parts of Rhizoma Cimicifugaes, 8 parts of Sanguis Draxonis, 5 parts of Os Draconis, 3 parts of Rhizoma Acori Graminei, 5 parts of Radix Notoginseng, 3 parts of Radix Angelicae Sinensis, 4 parts of Rhizoma Et Radix Notopterygiis, 10 parts of Myrrha (processed)s, 13 parts of Olibanum (processed)s, 9 parts of Radix Dipsacis, 3 parts of Borneolum Syntheticums, process powder.
Adopt various bleeding patients 96 examples of Drug therapy of the present invention, male's 80 examples wherein, women's 16 examples.
Therapeutic Method
Chinese medicine of the present invention 5-10 gram for oral administration at every turn, affected part suitable amount used externally.2-3 time on the one.
Efficacy assessment standard
Various hemorrhage clinical cures: can stop blooding in 1 day through using this medicine, wherein cure 96 examples.
The result
Various hemorrhage healing 96 examples, produce effects 0 example, invalid 0 example, cure rate: 100%, total effective rate 100%.
Produce effects: cardinal symptom disappears; Effectively: above-mentioned symptom alleviates; Invalid: clinical symptoms does not have improvement.
Claims (1)
1. treat wound, fracture rheumatism and various hemorrhage Chinese medicine for one kind; It is characterized in that; This Chinese medicine is made up of the crude drug of following parts by weight: Arisaema Cum Bile 6-8 part, Eupolyphaga Seu Steleophaga 6-8 part, Flos Carthami 6-8 part, Radix Angelicae Dahuricae 6-8 part, Rhizoma Chuanxiong 6-8 part, Rhizoma Cimicifugae 6-8 part, Sanguis Draxonis 6-8 part, Os Draconis 3-5 part, Rhizoma Acori Graminei 3-5 part, Radix Notoginseng 3-5 part, Radix Angelicae Sinensis 3-5 part, Rhizoma Et Radix Notopterygii 3-5 part, Myrrha (processed) 9-11 part, Olibanum (processed) 12-14 part, Radix Dipsaci 7-9 part, Borneolum Syntheticum 2-3 part, said each raw material pulverize is mixed and made into powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110232502A CN102274372B (en) | 2011-08-15 | 2011-08-15 | Traditional Chinese medicine for treating traumatic fracture rheumatism and various types of hemorrhage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110232502A CN102274372B (en) | 2011-08-15 | 2011-08-15 | Traditional Chinese medicine for treating traumatic fracture rheumatism and various types of hemorrhage |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102274372A CN102274372A (en) | 2011-12-14 |
| CN102274372B true CN102274372B (en) | 2012-10-10 |
Family
ID=45100317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110232502A Expired - Fee Related CN102274372B (en) | 2011-08-15 | 2011-08-15 | Traditional Chinese medicine for treating traumatic fracture rheumatism and various types of hemorrhage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102274372B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103705679B (en) * | 2013-12-25 | 2016-09-28 | 骆维忠 | A kind of ointment treating rheumatism |
| CN104815114A (en) * | 2015-05-14 | 2015-08-05 | 栾艳霞 | Traditional Chinese medicine ointment for treating bone fracture and production method thereof |
| CN113350435A (en) * | 2015-11-30 | 2021-09-07 | 张德东 | Application of composition in preparing medicine for treating traumatic injury, fracture dislocation, rheumatic bone disease and rheumatic arthritis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101062217A (en) * | 2007-05-24 | 2007-10-31 | 四川省宜宾五粮液集团有限公司 | Medicine combination for treating traumatic injury and the preparing method and the function thereof |
| CN101708258A (en) * | 2009-11-30 | 2010-05-19 | 郭洪勋 | Medicament for treating bone damage |
-
2011
- 2011-08-15 CN CN201110232502A patent/CN102274372B/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 黄亦琦.痹证的中医外治研究进展.《中医外治杂志》.1995,(第05期),26-27. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102274372A (en) | 2011-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102988657B (en) | Plaster for treating fracture and traumatic injury and preparation method of plaster | |
| CN104644943A (en) | Traditional Chinese medicine composition, medicinal moxibustion containing same and preparation method | |
| CN104189871A (en) | Medicated wine for treating osteoproliferation | |
| CN107158297A (en) | It is a kind of to treat traditional Chinese medicinal ointment of Orthopedic Pain and preparation method thereof | |
| CN102895460B (en) | Traditional Chinese medicine composition for fracture and soft tissue injury | |
| CN101524450B (en) | Oral traditional Chinese medicine for setting bones and relieving rigidity of muscles and preparation method thereof | |
| CN1970045B (en) | Externally applied Chinese medicine for treating cervical and lumbar spondylosis | |
| CN104225249A (en) | Oral-administration fracture-setting traditional Chinese medicine for treating fracture | |
| CN106511510A (en) | Medicine composition used for treating wind-cold-damp arthralgia and muscle and bone strain | |
| CN102274372B (en) | Traditional Chinese medicine for treating traumatic fracture rheumatism and various types of hemorrhage | |
| CN101322786B (en) | External-use medicament for treating bone fracture and traumatic injury | |
| CN102793888B (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis | |
| CN103565969A (en) | Traditional Chinese medicine composition for treating soft tissue injury and fracture | |
| CN103223076B (en) | Orally taken traditional Chinese medicine treating fractures | |
| CN105709074A (en) | Medicine for treating rheumatic arthritis and hyperostosis and preparation method | |
| CN104083568A (en) | Miao medicine plaster for ostealgia and preparation method thereof | |
| CN104258285A (en) | Medicine for treating lumbar bone hyperplasia through internal and external application and preparation method thereof | |
| CN109806351A (en) | Neck-shoulder pain, lumbago and leg pain temperature, which is applied, to be dissipated | |
| CN103585257A (en) | Traditional Chinese medicine powder for treating fractures | |
| CN102370836A (en) | External application traditional Chinese medicine for treating traumatic synovitis | |
| CN100512867C (en) | Traditional Chinese medicinal preparation for treating rheumatic arthritis, rheumatoid oarthritis, intervertebral disc and ischialgia neuralgia | |
| CN102228583B (en) | Chinese herbal composition and application thereof to preparing antirheumatic and antalgesic medicines | |
| CN105617214A (en) | Traditional Chinese medicine composition for treating scabies | |
| CN104587205B (en) | A kind of medicine for treating fracture | |
| CN105194411A (en) | Formula of traditional Chinese medicine for treating scapulobumeral periarthritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121010 Termination date: 20200815 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |